JBSS vs FRPT

For growth investors, Freshpet, Inc.

(FRPT) is the stronger pick with 13. 0% revenue growth year-over-year, versus 3. 8% for John B. Sanfilippo & Son, Inc. (JBSS). John B. Sanfilippo & Son, Inc. (JBSS) offers the better valuation at 15. 8x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate John B. Sanfilippo & Son, Inc. (JBSS) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, John B.

Sanfilippo & Son, Inc. (JBSS) is the cheapest at 15. 8x versus Freshpet, Inc. at 20. 8x. On forward P/E, John B. Sanfilippo & Son, Inc. is actually cheaper at 10. 9x.

Over the past 5 years, John B.

Sanfilippo & Son, Inc. (JBSS) delivered a total return of +5. 9%, compared to -68. 1% for Freshpet, Inc. (FRPT). Over 10 years, the gap is even starker: FRPT returned +515. 1% versus JBSS's +107. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), John B.

Sanfilippo & Son, Inc. (JBSS) is the lower-risk stock at 0. 31β versus Freshpet, Inc. 's 0. 91β — meaning FRPT is approximately 191% more volatile than JBSS relative to the S&P 500. On balance sheet safety, John B. Sanfilippo & Son, Inc. (JBSS) carries a lower debt/equity ratio of 28% versus 46% for Freshpet, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Freshpet, Inc.

(FRPT) is pulling ahead at 13. 0% versus 3. 8% for John B. Sanfilippo & Son, Inc. (JBSS). On earnings-per-share growth, the picture is similar: Freshpet, Inc. grew EPS 183. 9% year-over-year, compared to -2. 3% for John B. Sanfilippo & Son, Inc.. Over a 3-year CAGR, FRPT leads at 22. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Freshpet, Inc.

(FRPT) is the more profitable company, earning 12. 6% net margin versus 5. 3% for John B. Sanfilippo & Son, Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FRPT leads at 8. 6% versus 7. 7% for JBSS. At the gross margin level — before operating expenses — FRPT leads at 38. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, John B.

Sanfilippo & Son, Inc. (JBSS) trades at 10. 9x forward P/E versus 40. 4x for Freshpet, Inc. — 29. 5x cheaper on a one-year earnings basis.

In this comparison, JBSS (2.

6% yield) pays a dividend. FRPT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, John B.

Sanfilippo & Son, Inc. (JBSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), 2. 6% yield, +107. 6% 10Y return). Both have compounded well over 10 years (JBSS: +107. 6%, FRPT: +515. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: JBSS is a small-cap deep-value stock; FRPT is a small-cap quality compounder stock. JBSS pays a dividend while FRPT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.